cas 86254-08-2|| where to buy 3-((3,4-Dihydroisoquinolin-2(1H)-yl)methyl)-5,5-diphenylimidazolidine-2,4-dione

Nom du produit:3-((3,4-Dihydroisoquinolin-2(1H)-yl)methyl)-5,5-diphenylimidazolidine-2,4-dione

IUPAC Name:5,5-diphenyl-3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]imidazolidine-2,4-dione

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 86254-08-2 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:86254-08-2; Formule moléculaire:C25H23N3O2; Point de fusion:-; Code SMILES:O=C1N(CN2CC3=C(C=CC=C3)CC2)C(C(C4=CC=CC=C4)(C5=CC=CC=C5)N1)=O; Densité:

: Numéro de catalogue:CM267456; Poids moléculaire:397.48; Point d'ébullition:; N° Mdl:; Stockage:

: Imidazolidines; Imidazolidine is a heterocyclic compound (CH2)2(NH)2CH2. The parental imidazolidines are less studied, but related compounds substituted on one or both nitrogen centers are more common. Generally, they are colorless, polar, basic compounds. Imidazolidines are examples of cyclic 5-membered general amines. Imidazolidine derivatives are key components in the development of bioactive compounds for the treatment of various diseases, especially Chagas disease. In fact, other studies have shown that imidazoline-2,4-diones have a wide range of pharmacological activities, including anticonvulsant, antiarrhythmic, and antiparasitic.; imidazolidine supplier; As a imidazolidine supplier,we sincerely welcome the new and old friends from home and abroad to synergize with our company and share the benefits and opportunities.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.